Search Results for: insulin
-
Development and Pilot Testing of EHR-Nudges to Reduce Overuse in Older Primary Care Patients
Unnecessary testing and treatment of common conditions in older adults can lead to significant morbidity and mortality.
Categorized in -
Drugmakers Aren’t Driving Inflation. Price Controls Would Hinder Medical Progress
Drug prices have not experienced the major rise in cost like eggs or gasoline, and instituting price controls on drugs would only stifle medical innovation.
Categorized in -
PBMs Are Inflating the Cost of Generic Drugs. They Must Be Reined In
Anti-competitive practices and a lack of transparency in the generic drug market allow pharmacy benefit managers to profit off patients and payers.
Categorized in -
Race and Ethnic Differences in the Association Between Alzheimer’s Disease Risk and Use of Prescription Medications for Chronic Conditions
Schaeffer Center experts analyze the connection between medications for chronic diseases and their impact on Alzheimer’s as well as a lack of representation among racial and ethnic minorities in clinical trials.
Categorized in -
Schaeffer Center Research on the Pharmaceutical Distribution Chain
Schaeffer experts have studied the pharmaceutical distribution system and analyzed the evolving role of intermediaries since 2017.
Categorized in -
2021 Schaeffer Center Annual Report
At the Schaeffer Center, we’ve spent over a decade conducting evidence-based research to ensure access to high-value healthcare, build a healthcare system that is resilient and sustainable, and encourage biomedical innovation that improves quality of life.
Categorized in -
USC Schaeffer’s Rocio Ribero Was a Deep Thinker Who Loved Laughter, Her Family and Solving Problems
USC Price is remembering Rocio Ribero, a research scientist who produced groundbreaking work in the Schaeffer Center for Health Policy and Economics.
Categorized in -
Top Schaeffer Studies of 2021
Over the past year, Schaeffer Center experts authored over 130 journal articles and 14 white papers. They were also in the media about 5,500 times, including authoring over 40 op-eds and blog posts. Below is a look back at a few of the most impactful studies from 2021.
-
Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes
Research Design and Methods: Insured patients aged ≥18 years with newly diagnosed type 2 diabetes and 5 years of continuous enrollment were identified from a nationwide commercial claims database containing data from 2007 to 2015. The incidences of PDR, TRD, and NVG were computed at 5 years following the index diagnosis of type 2 diabetes. Associations between these outcomes and demographic, socioeconomic, and medical factors were tested with multivariable logistic regression.
Categorized in -
A Framework for Categorizing and Analyzing Prescription Drug Pricing Reform Options
Schaeffer Initiative experts present a framework for categorizing and analyzing a wide range of proposed policy reforms for prescription drug pricing.
Categorized in